SCHEMBL6976631

SCHEMBL6976631

N#Cc1ccc(CCC(=O)N2CCCc3cc(NCc4ccccc4)ccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.46
NR3C1 P04150 2/20 0.45
FFAR1 O14842 2/20 0.45
TP53 P04637 3/20 0.44
FPR1 P21462 2/20 0.44
FPR2 P25090 2/20 0.44
FFAR4 Q5NUL3 1/20 0.44
TSHR P16473 3/20 0.44
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
HPGD P15428 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.42
MAPT P10636 2/20 0.42
MAPK1 P28482 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976871 0.92 FFAR1 (0.49) NR3C1FFAR1TP53FPR1FPR2
SCHEMBL7090378 0.90 TP53 (0.47) NR3C1TP53FPR1FPR2TSHR
SCHEMBL6986003 0.89 RAB9A (0.48) NR3C1TP53FPR1FPR2TSHR
SCHEMBL6985994 0.88 POLB (0.43) NR3C1TP53FPR1FPR2TSHR
SCHEMBL6983653 0.88 FPR1 (0.44) NR3C1TP53FPR1FPR2TSHR
SCHEMBL6981983 0.88 RAB9A (0.46) NR3C1TP53FPR1FPR2TSHR
SCHEMBL6986809 0.87 RAB9A (0.51) NR3C1TP53FPR1FPR2ALDH1A1
SCHEMBL6979870 0.87 RAB9A (0.44) NR3C1FFAR1TP53FPR1FPR2
SCHEMBL6985562 0.86 NR3C1 (0.56) NR3C1FPR1FPR2TSHRALDH1A1
SCHEMBL6985377 0.86 RAB9A (0.62) NR3C1TP53FPR1FPR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed